Sialic Acids in the Immune Response during Sepsis

Bibliographic Details
Title: Sialic Acids in the Immune Response during Sepsis
Authors: Yan-Cun Liu, Mu-Ming Yu, Yan-Fen Chai, Song-Tao Shou
Source: Frontiers in Immunology, Vol 8 (2017)
Publisher Information: Frontiers Media S.A., 2017.
Publication Year: 2017
Collection: LCC:Immunologic diseases. Allergy
Subject Terms: sialic acid-binding immunoglobulin-type lectins, sepsis, infection, sialic acid, inflammation, Immunologic diseases. Allergy, RC581-607
More Details: Sialic acid-binding immunoglobulin-type lectins (Siglecs) are a group of cell surface transmembrane receptors expressed on immune cells, and regulate immune balance in inflammatory diseases. Sepsis is a life-threatened inflammatory syndrome induced by infection, and the pathogenesis of sepsis includes immune dysregulation, inflammation, and coagulation disorder. Here, we reviewed the various roles acted by Siglecs family in the pathogenesis of sepsis. Siglec-1, Siglec-5, and Siglec-14 play bidirectional roles through modulation of inflammation and immunity. Siglec-2 regulates the immune balance during infection by modulating B cell and T cell response. Siglec-9 helps endocytosis of toll-like receptor 4, regulates macrophages polarization, and inhibits the function of neutrophils during infection. Siglec-10 inhibits danger-associated molecular patterns induced inflammation, helps the initiation of antigen response by T cells, and decreases B-1a cell population to weaken inflammation. Regulating the Siglecs function in the different stages of sepsis holds great potential in the therapy of sepsis.
Document Type: article
File Description: electronic resource
Language: English
ISSN: 1664-3224
Relation: http://journal.frontiersin.org/article/10.3389/fimmu.2017.01601/full; https://doaj.org/toc/1664-3224
DOI: 10.3389/fimmu.2017.01601
Access URL: https://doaj.org/article/bf24309a56e94ecab3634c1d3f7f9604
Accession Number: edsdoj.bf24309a56e94ecab3634c1d3f7f9604
Database: Directory of Open Access Journals
More Details
ISSN:16643224
DOI:10.3389/fimmu.2017.01601
Published in:Frontiers in Immunology
Language:English